The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) aims to provide U.S. military forces and the nation with safe, effective, and innovative medical solutions to counter chemical, biological, radiological, and nuclear threats. The JPM CBRN Medical facilitates the advanced development and acquisition of medical countermeasures and systems to enhance the nation’s biodefense response capability.
Overview
The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical’s Vaccine Acceleration by Modular Progression (VAMP) is a nucleic acid vaccine development platform that facilitates rapid delivery of safe and effective nucleic acid based vaccines to the warfighter or the general population. VAMP relies on a modular contracting strategy to fund development of multiple mRNA vaccine candidates simultaneously, delivering mRNA vaccines against new and emerging biological threats to enhance overall preparedness.